Document Detail

The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs.
MedLine Citation:
PMID:  17072705     Owner:  NLM     Status:  MEDLINE    
A major risk associated with bupivacaine during myocardial ischemia is ventricular fibrillation. We investigated the influence of ropivacaine on cardiac contractility and the propensity to ventricular fibrillation before and after myocardial ischemia in a placebo-controlled pig study. Anesthetized domestic pigs were administered 1 of ropivacaine intravenously over 1 min and then 0.03 as a 30-min infusion, or saline. The following endpoints were measured before and after ropivacaine administration: (1) the ventricular fibrillation threshold (VFT) before and during myocardial ischemia induced by total transient ligation of the anterior interventricular artery and (2) electrophysiological (sinus heart rate, duration of QRS and QT intervals) and hemodynamic (blood pressure, the time derivative of left ventricular pressure [peak LV dP/dt]) parameters. Ropivacaine induced no changes in sinus heart rate, QRS, and or QT before or during ischemia. In contrast, there was a mild increase in the VFT before ischemia, which was drastically and significantly reduced during ischemia. The reduction of peak LV dP/dt during ischemia was further increased by ropivacaine. We also found that the effect of ropivacaine on the VFT was coronary blood flow-dependent, with a markedly decreased threshold in the presence of ischemia. Similar effects have been observed in humans with several other local anesthetics, as well as with class I antiarrhythmic drugs. The results of this study should be taken into account by anesthesiologists when administering ropivacaine to coronary patients.
Panayota Tsibiribi; Cécile Bui-Xuan; Bernard Bui-Xuan; Alain Tabib; Jacques Descotes; Philippe Chevalier; Marie-Claude Gagnieu; Majda Belkhiria; Quadiri Timour
Related Documents :
23067355 - A characterization and targeting of the infarct border zone in a swine model of myocard...
1985625 - Silent myocardial ischemia during rehabilitation for cerebrovascular disease.
1716425 - Quantitation of early myocardial ischemia using acridine orange fluorescence--an experi...
1615875 - Silent myocardial ischemia in men with systemic hypertension and without clinical evide...
2546415 - Instantaneous transmitral flow using doppler and m-mode echocardiography: comparison wi...
16970715 - Role of contrast-enhanced dobutamine stress echocardiography in predicting outcome in p...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of anesthesia     Volume:  20     ISSN:  0913-8668     ISO Abbreviation:  J Anesth     Publication Date:  2006  
Date Detail:
Created Date:  2006-10-30     Completed Date:  2007-01-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8905667     Medline TA:  J Anesth     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  341-3     Citation Subset:  IM    
Laboratoire de Pharmacologie Médicale (EA 1896), Faculté de Médecine Lyon Grange-Blanche, 8 avenue Rockefeller, 69373, Lyon, cedex 08, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amides / pharmacology*
Anesthetics, Local / pharmacology*
Monitoring, Physiologic
Myocardial Contraction / drug effects*
Myocardial Ischemia / physiopathology*
Ventricular Fibrillation / chemically induced*,  physiopathology
Reg. No./Substance:
0/Amides; 0/Anesthetics, Local; 84057-95-4/ropivacaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The benefits of adding epidural analgesia to general anesthesia: a metaanalysis.
Next Document:  Flexible, tapered-tip tube facilitates conventional orotracheal intubation by novice intubators.